Omada Health (Nasdaq: OMDA), the virtual-first provider of between-visit care, announced new study results demonstrating that Omada members in its GLP-1 Care Track lost, on average, 1.8 times more ...
As weight‑loss drugs surge in popularity, a study raises a new question about what patients may be losing along the way.
Men’s Fitness aims to feature only the best products and services. If you buy something via one of our links, we may earn a ...
A new study suggests that Eli Lilly’s GLP-1 drug tirzepatide, marketed as Zepbound and Mounjaro, leads to greater overall ...
Here’s what to know about body composition numbers and what these metrics mean for your health and performance.
Sarcopenia, a condition involving age-related muscle loss and weakness, significantly increases the risk of death in people over 100 years old, according to new research that followed 98 centenarians ...
Omada Health (Nasdaq: OMDA), the virtual-first provider of between-visit care, announced new study results demonstrating that Omada members in its GLP-1 Care ...